Environmental and economic analysis for selection and engineering sustainable API degenotoxification processes

Green Chemistry

Volumn 15, Issue 1, 2013, Pages 210-225

  Székely, György ^a,b   Gil, Marco ^a   Sellergren, Börje ^b   Heggie, William ^a   Ferreira, Frederico Castelo ^c  

^a Hovione FarmaCiencia SA   (Portugal)

^b TU DORTMUND UNIVERSITY   (Germany)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

APIS;

EID: 84871795166     PISSN: 14639262     EISSN: 14639270     Source Type: Journal    
DOI: 10.1039/c2gc36239b     Document Type: Article

References (47)

1. K. Cziner T. Virkki-Hatakka M. Hurme I. Turunen Evaluative approach for process development Chem. Eng. Technol. 2005 28 1490 1499
2. M. Degerman N. Jakobsson B. Nilsson Designing robust preparative purification processes with high performance Chem. Eng. Technol. 2008 31 875 882
3. T. Winkelnkemper G. Schembecker Purification fingerprints for experimentally based systematic downstream process development Sep. Purif. Technol. 2010 71 356 366
4. C. Jimenez-Gonzalez D. J. C. Constable C. S. Ponder Evaluating the "Greenness" of chemical processes and products in the pharmaceutical industry - a green metrics primer Chem. Soc. Rev. 2012 41 1485 1498
5. C. Jimenez-Gonzalez C. S. Ponder Q. B. Broxterman J. B. Manley Using the right green yardstick: why process mass intensity is used in the pharmaceutical industry to drive more sustainable processes Org. Process Res. Dev. 2011 15 912 917
6. D. J. C. Constable A. D. Curzons V. L. Cunningham Metrics to 'green' chemistry - which are the best? Green Chem. 2002 4 521 527
7. A. D. Curzons D. J. C. Constable D. N. Mortimer V. L. Cunningham So you think your process is green, how do you know? - Using principles of sustainability to determine what is green-a corporate perspective Green Chem. 2001 3 1 6
8. C. Jimenez-Gonzalez P. Poechlauer Q. B. Broxterman B. S. Yang D. am Ende J. Baird C. Bertsch R. E. Hannah P. Dell'Orco H. Noorman S. Yee R. Reintjens A. Wells V. Massonneau J. Manley Key green engineering research areas for sustainable manufacturing: a perspective from pharmaceutical and fine chemicals manufacturers Org. Process Res. Dev. 2011 15 900 911
9. Gy. Székely J. Bandarra W. Heggie B. Sellergren F. C. Ferreira Organic solvent nanofiltration: a platform for removal of genotoxins from active pharmaceutical ingredients J. Membr. Sci. 2011 381 21 33
10. R. Kecili D. Nivhede J. Billing M. Leeman B. Sellergren E. Yilmaz Removal of acrolein from active pharmaceutical ingredients using aldehyde scavengers Org. Process Res. Dev. 2012 16 1225 1229
11. Gy. Székely E. Fritz J. Bandarra W. Heggie B. Sellergren Removal of potentially genotoxic acetamide and arylsulfonate impurities from crude drugs by molecular imprinting J. Chromatogr., A 2012 1240 52 58
12. J. Bousquet Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma Int. J. Clin. Pract. 2009 63 806 819
13. D. Kwok, D. J. Tsai, C. Tann and X. Fu, Process for the preparation of 17-esters of 9α,21-dihalo-pregnane-11β,17α-diol-20-ones, WO9800437, June 1997
14. E. L. Shapiro, 3,20-dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocycle carboxylates, US4,472,393, Sept 1984
15. W. Heggie and J. Bandarra, Process for the preparation of mometasone furoate, US 6,177,560, Jan 2001
16. R. W. Draper B. Hu A. T. McPhail M. S. Puar E. J. Vater L. Weber Unusual hydroxy-γ-sultone byproducts of steroid 21-methanesulfonylation: an efficient synthesis of mometasone 17-furoate (Sch 32088) Tetrahedron 1999 55 3355 3364
17. C. K. Hwang W. S. Li K. C. Nicolaou Reactions of hydroxyl groups with tosylchloride-dimethylaminopyridine system: direct synthesis of chlorides from hydroxycompounds Tetrahedron Lett. 1984 25 2295 2296
18. 3N·HCl as combined base: promising alternative to traditional pyridine Tetrahedron 1999 55 2183 2192
19. L. Muller R. J. Mauthe C. M. Riley M. M. Andino D. De Antonis C. Beels J. DeGeorge A. G. M. De Knaep D. Ellison J. A. Fagerland R. Frank B. Fritschel S. Galloway E. Harpur C. D. N. Humfrey A. S. Jacks N. Jagota J. Mackinnon G. Mohan D. K. Ness M. R. O'Donovan M. D. Smith G. Vudathala L. Yotti A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity Regul. Toxicol. Pharmacol. 2006 44 3 198 211
20. G. Székely J. Bandarra W. Heggie F. C. Ferreira B. Sellergren Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions Sep. Purif. Technol. 2012 86 190 198
21. S. Darvishmanesh L. Firoozpour J. Vanneste P. Luis J. Degreve B. Van der Bruggen Performance of solvent resistant nanofiltration membranes for purification of residual solvent in the pharmaceutical industry: experiments and simulation Green Chem. 2011 13 3476 3483
22. J. T. Scarpello D. Nair L. M. F. dos Santos L. S. White A. G. Livingston The separation of homogeneous organometallic catalysts using solvent resistant nanofiltration J. Membr. Sci. 2002 203 71 85
23. E. Rundquist C. Pink E. Vilminot A. Livingston Facilitating the use of counter-current chromatography in pharmaceutical purification through use of organic solvent nanofiltration J. Chromatogr., A 2012 1229 156 163
24. Q. Nie J. Wang Q. Yin Separation and purification of two isomorphic steroids by a novel extractive drowning out crystallization Sep. Purif. Technol. 2006 50 342 346
25. Gy. Székely J. Bandarra W. Heggie B. Sellergren F. C. Ferreira A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea Sep. Purif. Technol. 2012 86 79 87
26. B. P. Chekal A. M. Campeta Y. A. Abramov N. Feeder P. P. Glynn R. W. McLaughlin P. A. Meenan R. A. Singer The challenges of developing an API crystallization process for a complex polymorphic and highly solvating system Org. Process Res. Dev. 2009 13 1327 1337
27. E. Rundquist C. Pink A. Livingston Organic solvent nanofiltration: a potential alternative to distillation for solvent recovery from crystallisation mother liquors Green Chem. 2012 14 2197 2205
28. W. M. Nelson, Green Solvents for Chemistry: Perspectives and Practice, Oxford University Press, 2003 (Table 7.2 and Table 7.12)
29. Chemistry Innovation website-February 2010, http://www. chemistryinnovation.co.uk/roadmap/sustainable/roadmap.asp?id=84
30. A. D. Curzons D. C. Constable V. L. Cunningham Solvent selection guide: a guide to the integration of environmental, health and safety criteria into the selection of solvents Clean Prod. Process. 1999 1 82 90
31. R. K. Henderson C. Jiménez-González D. J. C. Constable S. R. Alston G. G. A. Inglis G. Fisher J. Sherwood S. P. Binks A. D. Curzons Expanding GSK's solvent selection guide-embedding sustainability into solvent selection starting at medicinal chemistry Green Chem. 2011 13 854 862
32. K. Alfonsi J. Colberg P. J. Dunn T. Fevig S. Jennings T. A. Johnson H. Peter Kleine C. Knight M. A. Nagy D. A. Perry M. Stefaniak Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation Green Chem. 2008 10 31 33
33. A. D. Curzons D. C. Constable V. L. Cunningham Solvent selection guide: a guide to the integration of environmental, health and safety criteria into the selection of solvents Clean Prod. Process. 1999 1 82 90
34. R. K. Henderson C. Jiménez-González D. J. C. Constable S. R. Alston G. G. A. Inglis G. Fisher J. Sherwood S. P. Binks A. D. Curzons Expanding GSK's solvent selection guide-embedding sustainability into solvent selection starting at medicinal chemistry Green Chem. 2011 13 854 862
35. D. J. C. Constable C. Jimenez-Gonzalez R. K. Henderson Perspective on Solvent Use in the Pharmaceutical Industry Org. Process Res. Dev. 2007 11 133 137
36. M. Berrios R. L. Skelton Comparison of purification methods for biodiesel Chem. Eng. J. 2008 144 459 465
37. T. Winkelnkemper G. Schembecker Purification performance index and separation cost indicator for experimentally based systematic downstream process development Sep. Purif. Technol. 2010 72 34 39
38. J. García-Serna J. L. Martínez M. J. Cocero Green HAZOP analysis: incorporating green engineering into design, assessment and implementation of chemical processes Green Chem. 2007 9 111 124
39. C. Jimenez-Gonzalez A. D. Curzons D. J. C. Constable V. L. Cunningham Cradle-to-gate life cycle inventory and assessment of pharmaceutical compounds Int. J. Life Cycle Assess. 2004 9 2 114 121
40. C. Jimenez-Gonzalez A. D. Curzons D. J. C. Constable M. R. Overcash V. L. Cunningham How do you select the "greenest" technology? Development of guidance for the pharmaceutical industry Clean Prod. Processes 2001 3 35 41
41. R. K. Sinnott, Chemical Engineering Design, Butterworth-Heinemann, 4 edn, vol. 6, 2005
42. Impact assessment of potential restrictions on the marketing and use of dichloromethane in paint strippers, Final report for European Commission's Directorate-General Enterprise and Industry by Risk & Policy Analysts Limited, Norfolk, UK, 2007
43. S. Lee and G. Robinson, Process Development Fine Chemicals from Grams, Oxford University Press, 1995
44. Impact assessment of potential restrictions on the marketing and use of dichloromethane in paint strippers, Final Report-April 2007, prepared for European Commission Directorate-General Enterprise and Industry by Risk & Policy Analysts Limited, Norfolk, UK
45. Gy. Székely B. Henriques M. Gil A. Ramos C. Alvarez Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids J. Pharm. Biomed. Anal. 2012 70 251 258
46. W. Clark Still M. Kahn A. Mitra Rapid chromatographic technique for preparative separations with moderate resolution J. Org. Chem. 1978 43 14 2923 2925
47. M. Mulder, Basic Principles of Membrane Technology, Kluwer Academic Publishers, Dordrecht, Netherlands, 1996